Access the full text.
Sign up today, get DeepDyve free for 14 days.
Risk reduction strategies for women at an increased risk for breast cancer include prophylactic mastectomy, prophylactic salpingo-oophorectomy, and chemoprevention. These techniques have been well studied in certain high-risk populations such as women with significant family histories of breast cancer and women with BRCA1 and BRCA2 mutations. Rapid evolution in genetic testing technology has enabled increased access and ability to analyze genes associated with an increased risk for breast cancer. These genes include but are not limited to BRCA1 and BRCA2. This technological progress has expanded the definition and number of women classified as having a genetic predisposition to breast cancer; however, literature specifically evaluating efficacy of breast cancer risk reduction strategies in this expanded population does not yet exist. In order to appreciate the effectiveness of risk-reducing strategies for women with a hereditary predisposition to breast cancer, we provide an overview of current literature and recommendations for risk-reducing mastectomy, risk-reducing salpingo-oophorectomy, and chemoprevention in the high-risk breast cancer population.
Current Breast Cancer Reports – Springer Journals
Published: Aug 8, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.